Photodynamic bone stabilization systems and methods for reinforcing bone

Information

  • Patent Grant
  • 8574233
  • Patent Number
    8,574,233
  • Date Filed
    Friday, September 14, 2012
    12 years ago
  • Date Issued
    Tuesday, November 5, 2013
    11 years ago
Abstract
Photodynamic bone stabilization systems are disclosed herein. In an embodiment, a photodynamic bone stabilization system includes a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween; a light-conducting fiber configured to transmit light energy to the expandable portion; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy to initiate polymerization of the light-sensitive liquid monomer; and a cooling medium configured to control polymerization temperature, wherein the catheter comprises an inner void sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, and wherein the catheter comprises an inner lumen sufficiently designed to pass the light-conducting fiber into the expandable portion and configured to circulate the cooling medium.
Description
FIELD

The embodiments disclosed herein relate to minimally invasive orthopedic procedures, and more particularly to photodynamic bone stabilization systems for use in repairing a weakened or fractured bone.


BACKGROUND

Bone fracture repairs are surgical procedures to realign and stabilize broken bones, and are conventionally carried out using plates, nails, screws or pins. Current methods of treating bone fractures each have significant drawbacks. For example, tendon adhesions are typical in casting; soft tissue injury occurs frequently when plates or screws are inserted during open surgery; and K-wires do not provide sufficient support for immediate movement. Frequently, these procedures require extensive post operative recuperation and present with co-morbidities, such as, stiffness and loss of range of motion. For example, post surgical soft tissue injury can reduce mobility, and callous may incorporate into surrounding tendons further reducing mobility.


SUMMARY

Photodynamic bone stabilization systems are disclosed herein. According to aspects illustrated herein, a photodynamic bone stabilization system includes a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween; a light-conducting fiber configured to transmit light energy to the expandable portion; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy to initiate polymerization of the light-sensitive liquid monomer; and a cooling medium configured to control polymerization temperature, wherein the catheter comprises an inner void sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, and wherein the catheter comprises an inner lumen sufficiently designed to pass the light-conducting fiber into the expandable portion and configured to circulate the cooling medium.


According to aspects illustrated herein, a photodynamic bone stabilization system includes a light-conducting fiber configured to transmit light energy; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy; a pressurizing medium configured to control polymerization shrinkage; and a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween, wherein the catheter comprises an inner void and an inner lumen, wherein the inner void is sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, wherein the inner lumen is sufficiently designed to pass the light-conducting fiber into the expandable portion, and wherein the inner lumen comprises expandable portions configured to expand when the pressurizing medium is delivered to the inner lumen so as to cause internal diameter pressure against the light-sensitive liquid monomer contained within the expandable portion during polymerization.


According to aspects illustrated herein, a method includes providing a system comprising a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween; a light-conducting fiber configured to transmit light energy to the expandable portion; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy, to initiate polymerization of the light-sensitive liquid monomer; and a cooling medium configured to control polymerization temperature, wherein the catheter comprises an inner void sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, and wherein the catheter comprises an inner lumen sufficiently designed to pass the light-conducting fiber into the expandable portion and configured to circulate the cooling medium; inserting the expandable portion of the system into an intramedullary canal spanning a fracture site comprising a plurality of fractured pieces; infusing the light-sensitive liquid monomer into the inner void of the catheter so that the light-sensitive liquid monomer expands the expandable portion until the fractured pieces are substantially restored to their natural positions; inserting the light-conducting fiber into the inner lumen of the catheter so that the light-conducting fiber resides in the expandable portion; activating the light-conducting fiber to transmit light energy to the expandable portion to initiate in situ polymerization of the light-sensitive liquid monomer within the expandable portion; infusing the cooling medium into the inner lumen of the catheter to control polymerization temperature; and completing the in situ polymerization of the light-sensitive liquid monomer to harden the expandable portion at the fracture site.





BRIEF DESCRIPTION OF THE DRAWINGS

The presently disclosed embodiments will be further explained with reference to the attached drawings, wherein like structures are referred to by like numerals throughout the several views. The drawings shown are not necessarily to scale, with emphasis instead generally being placed upon illustrating the principles of the presently disclosed embodiments.



FIG. 1 shows a side view of an embodiment of a proximal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone according to the present disclosure. The distal end includes an expandable portion (illustrated in an expanded position) having means for preventing shrinkage of at least a portion of the expandable portion.



FIG. 2 shows a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured long bone according to the present disclosure.



FIG. 3 shows a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone according to the present disclosure. The distal end includes an expandable portion (illustrated in an expanded position) having an internal lumen penetrating through a distal end of the expandable portion for cooling through the length of the expandable portion.



FIG. 4 shows a side view of the expandable portion of FIG. 3 after a light-sensitive liquid has been added to the expandable portion and a curing process has been initiated. A light-conducting fiber introduced into the inner lumen of the expandable portion is activated, while a cooling medium flows through the inner lumen and out the distal end of the expandable portion.



FIGS. 5A-5D illustrate an embodiment of a procedure for repairing a weakened or fractured bone. FIG. 5A is a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone positioned within a fractured bone. The distal end includes an expandable portion having an internal lumen penetrating through a distal end of the expandable portion for cooling through the length of the expandable portion. The distal end of the expandable portion releaseably engages a catheter. FIG. 5B is a side view of the expandable portion of FIG. 5A after a light-sensitive liquid monomer has been added to the expandable portion, causing the expandable portion to inflate. FIG. 5C is a side view of the expandable portion of FIG. 5A after a light-conducting fiber has been inserted into the expandable portion to transmit energy to initiate a curing process. FIG. 5D is a side view of the hardened expandable portion of FIG. 5A positioned within the weakened or fractured bone after the catheter has been released.



FIG. 6 shows a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone according to the present disclosure. The distal end includes an expandable portion (illustrated in an expanded position) having an internal lumen with a return flow path for cooling.



FIG. 7 shows a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone according to the present disclosure. The distal end includes an expandable portion (illustrated in an expanded position) having an external helical design tubing for providing cooling medium to the expandable portion.



FIG. 8A shows a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone according to the present disclosure. The distal end includes an expandable portion (illustrated in an expanded position) having external stiffening members.



FIG. 8B shows a sectional view of the expandable portion of FIG. 8A taken along line B-B.



FIG. 9A shows a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone according to the present disclosure. The distal end includes an expandable portion (illustrated in an expanded position) having external stiffening members interconnected with one another via connecting means.



FIG. 9B shows a sectional view of the expandable portion of FIG. 9A taken along line B-B.



FIG. 10A shows a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone according to the present disclosure. The distal end includes an expandable portion (illustrated in an expanded position) having internal stiffening members.



FIG. 10B shows a sectional view of the expandable portion of FIG. 10A taken along line B-B.



FIG. 11A shows a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone according to the present disclosure. The distal end includes an expandable portion (illustrated in an expanded position) having internal stiffening members.



FIG. 11B shows a sectional view of the balloon portion of FIG. 11A taken along line B-B.



FIG. 12A shows a side view of an embodiment of a distal end of a photodynamic bone stabilization system for repairing a weakened or fractured bone according to the present disclosure. The distal end includes an expandable portion (illustrated in an expanded position) having external stiffening members that move into a corrugated shape upon a temperature change, as well as a means for cooling the expandable portion.



FIGS. 12B-12G show cross-sectional views of various embodiments of metallic memory-type metal pieces for use as external or internal stiffening members for an expandable portion of a system of the present disclosure. FIG. 12B shows a stiffening member having a rectangular cross-section. FIG. 12C shows a stiffening member having a trapezoid cross-section. FIG. 12D shows a stiffening member having a unique cross-section. FIG. 12E shows a stiffening member having a triangular cross-section. FIG. 12F shows a stiffening member having a bow-tie cross-section. FIG. 12G shows a stiffening member having a rounded rectangular cross-section.





While the above-identified drawings set forth presently disclosed embodiments, other embodiments are also contemplated, as noted in the discussion. This disclosure presents illustrative embodiments by way of representation and not limitation. Numerous other modifications and embodiments can be devised by those skilled in the art which fall within the scope and spirit of the principles of the presently disclosed embodiments.


DETAILED DESCRIPTION

The embodiments disclosed herein relate to minimally invasive orthopedic procedures, and more particularly to photodynamic bone stabilization systems for use in repairing a weakened or fractured bone. In an embodiment, a photodynamic bone stabilization system includes a thin-walled, non-compliant, expandable portion releasably mounted on a small diameter, flexible insertion catheter. In an embodiment, the expandable portion is adapted to reside within an inner cavity of at least two bone fragments and provide support to the bone fragments. In an embodiment, the expandable portion is adapted to reside within an inner cavity of at least two bone fragments and secure the bone fragments in a relatively fixed relationship to each another, thus ensuring that the fractured bone can regenerate in the proper orientation and fuse the fracture.


In an embodiment, a photodynamic bone stabilization system of the present disclosure is used to treat a fracture including, but not limited to, a hand fracture, a wrist fracture, a radius fracture, an ulna fracture, a clavicle fracture, a metacarpal fracture, a phalanx fracture, a metatarsal fracture, a phalange fracture, a tibia fracture, a fibula fracture, a humerus fracture, and a rib fracture. Long bones are the large bones in the arms and legs, and include the humerus, the radius/ulna, the femur and the tibia/fibula. In an embodiment, a photodynamic bone stabilization system of the present disclosure is used to reinforce a fractured long bone. In an embodiment, a photodynamic bone stabilization system of the present disclosure is used to stabilize a fractured long bone in conjunction with anatomic reduction (i.e., proper reorientation of fractured elements to their original position, both relative to one another and relative to other adjacent anatomical features).



FIG. 1 shows an embodiment of a proximal end 112 of a flexible insertion catheter 101 of a photodynamic bone stabilization system of the present disclosure for repairing a weakened or fractured bone. The photodynamic bone stabilization system includes a thin-walled, non-compliant, expandable portion (not visible in FIG. 1) releasably mounted at a distal end of the flexible insertion catheter 101. In an embodiment, the flexible insertion catheter 101 includes one or more radiopaque markers or bands positioned at various locations. The one or more radiopaque bands, using radiopaque materials such as barium sulfate, tantalum, or other materials known to increase radiopacity, allows a medical professional to view the insertion catheter 101 using fluoroscopy techniques. A proximal end adapter 105 includes at least one arm and at least one adapter which can be utilized for the infusion and withdrawal of fluids or as conduits for the introduction of devices (e.g., a light-conducting fiber). In an embodiment, an adapter is a Luer lock. In an embodiment, an adapter is a Tuohy-Borst connector. In an embodiment, an adapter is a multi-functional adapter. FIG. 1 shows a side view of a three arm proximal end fitting having three adapters 115, 125, and 135. Adapter 115 can accept, for example, a light-conducting fiber. Adapter 125 can accept, for example, air or fluid. In an embodiment, adapter 125 can accept, for example, a cooling medium. In an embodiment, adapter 125 can accept, for example, pressurizing medium. Adapter 135 can accept, for example, a syringe housing a light-sensitive liquid. In an embodiment, the light-sensitive liquid is a liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits light energy. In an embodiment, the viscosity of the light-sensitive liquid is about 1000 cP or less. In an embodiment, the light-sensitive liquid has a viscosity ranging from about 650 cP to about 450 cP. Low viscosity allows filling of the expandable portion through a very small delivery system.


In an embodiment, a syringe housing light-sensitive liquid is attached to the adapter 135 at the proximal end 112 of the insertion catheter 101, and during use of the photodynamic bone stabilization system, the syringe plunger is pushed, allowing the syringe to expel the light-sensitive liquid into an inner void 110 (not visible in FIG. 1) of the photodynamic bone stabilization system. As the light-sensitive liquid is expelled through the inner void, it reaches the expandable portion to move the expandable portion from a deflated state to an inflated state. The light-sensitive liquid can be aspirated and reinfused as necessary, allowing for adjustments to the expandable portion prior to curing of the light-sensitive liquid, wherein curing of the light-sensitive liquid hardens the expandable portion in a desired position to stabilize the fracture. These properties allow a user to achieve maximum fracture reduction prior to activating a light source and converting the liquid monomer into a hard polymer.


In an embodiment, a light-conducting fiber communicating light from a light source is introduced into adapter 115 at the proximal end 112 of the insertion catheter 101 to pass the light-conducting fiber within an inner lumen 120 (not visible in FIG. 1) of the photodynamic bone stabilization system. In an embodiment, the light-conducting fiber is an optical fiber. Optical fibers may be used in accordance with the present disclosure to communicate light from the light source to the remote location. Optical fibers use a construction of concentric layers for optical and mechanical advantages. The most basic function of a fiber is to guide light, i.e., to keep light concentrated over longer propagation distances—despite the natural tendency of light beams to diverge, and possibly even under conditions of strong bending. In the simple case of a step-index fiber, this guidance is achieved by creating a region with increased refractive index around the fiber axis, called the fiber core, which is surrounded by the cladding. The cladding is usually protected with at least a polymer coating. Light is kept in the “core” of the optical fiber by total internal reflection. Cladding keeps light traveling down the length of the fiber to a destination. In some instances, it is desirable to conduct electromagnetic waves along a single guide and extract light along a given length of the guide's distal end rather than only at the guide's terminating face. In some embodiments of the present disclosure, at least a portion of a length of an optical fiber is modified, e.g., by removing the cladding, in order to alter the direction, propagation, amount, intensity, angle of incidence, uniformity and/or distribution of light.


The optical fiber can be made from any material, such as glass, silicon, silica glass, quartz, sapphire, plastic, combinations of materials, or any other material, and may have any diameter, as not all embodiments of the present disclosure are intended to be limited in this respect. In an embodiment, the optical fiber is made from a polymethyl methacrylate core with a transparent polymer cladding. The optical fiber can have a diameter between approximately 0.75 mm and approximately 2.0 mm. In some embodiments, the optical fiber can have a diameter of about 0.75 mm, about 1 mm, about 1.5 mm, about 2 mm, less than about 0.75 mm or greater than about 2 mm as not all embodiments of the present disclosure are intended to be limited in this respect. In an embodiment, the optical fiber is made from a polymethyl methacrylate core with a transparent polymer cladding. It should be appreciated that the above-described characteristics and properties of the optical fibers are exemplary and not all embodiments of the present disclosure are intended to be limited in these respects. Light energy from a visible emitting light source can be transmitted by the optical fiber. In an embodiment, visible light having a wavelength spectrum of between about 380 nm to about 780 nm, between about 400 nm to about 600 nm, between about 420 nm to about 500 nm, between about 430 nm to about 440 nm, is used to cure the light-sensitive liquid.


The light-sensitive liquid remains a liquid monomer until activated by the light-conducting fiber (cures on demand). Radiant energy from the light-conducting fiber is absorbed and converted to chemical energy to quickly polymerize the monomer. This cure affixes the expandable portion in an expanded shape. A cure may refer to any chemical, physical, and/or mechanical transformation that allows a composition to progress from a form (e.g., flowable form) that allows it to be delivered through the inner void in the insertion catheter 101, into a more permanent (e.g., cured) form for final use in vivo. For example, “curable” may refer to uncured composition, having the potential to be cured in vivo (as by catalysis or the application of a suitable energy source), as well as to a composition in the process of curing (e.g., a composition formed at the time of delivery by the concurrent mixing of a plurality of composition components).


The presently disclosed embodiments provide expandable portions of photodynamic bone stabilization systems of the present disclosure. It should be understood that any of the expandable portions disclosed herein may include one or more radiopaque markers or bands. For example, a radiopaque ink bead may be placed at a distal end of the expandable portion for alignment of the system during fluoroscopy. The one or more radiopaque bands and radiopaque ink bead, using radiopaque materials such as barium sulfate, tantalum, or other materials known to increase radiopacity, allows a medical professional to view the expandable portion during positioning to properly position the expandable during a repair procedure, and allows the medical professional to view the expandable portion during inflation and/or deflation to properly stabilize and align the fractured bones. In an embodiment, the one or more radiopaque bands permit visualization of any voids that may be created by air that gets entrapped in the expandable portion. In an embodiment, the one or more radiopaque bands permit visualization to preclude the expandable portion from misengaging or not meeting a bone due to improper inflation to maintain a uniform expandable/bone interface.


It should be understood that any of the expandable portions disclosed herein may be round, flat, cylindrical, oval, rectangular or any desired shape for a given application. The expandable portion may be formed of a pliable, resilient, conformable, and strong material, including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In an embodiment, the expandable portion is constructed out of a PET nylon aramet or other non-consumable materials. In an embodiment, the expandable portion may be formed from a material that allows the expandable portion to conform to obstructions or curves at the site of implantation.


It should be understood that any of the expandable portions disclosed herein by way of example, but not of limitation, can have the following dimensions: In an embodiment, the expandable portion has a diameter ranging from about 5 mm to about 20 mm. In an embodiment, the expandable portion has a length ranging from about 20 mm to about 450 mm. In an embodiment, the expandable portion has a diameter of about 5 mm and a length of about 30 mm. In an embodiment, the expandable portion has a diameter of about 5 mm and a length of about 40 mm. In an embodiment, the expandable portion has a diameter of about 6 mm and a length of about 30 mm. In an embodiment, the expandable portion has a diameter of about 6 mm and a length of about 40 mm. In an embodiment, the expandable portion has a diameter of about 6 mm and a length of about 50 mm. In an embodiment, the expandable portion has a diameter of about 7 mm and a length of about 30 mm. In an embodiment, the expandable portion has a diameter of about 7 mm and a length of about 40 mm. In an embodiment, the expandable portion has a diameter of about 7 mm and a length of about 50 mm. In an embodiment, the expandable portion has a diameter of about 14 mm and a length of about 400 mm. In an embodiment, the expandable portion has a diameter of about 14 mm and a length of about 300 mm.


It should be understood that any of the expandable portions disclosed herein includes an outer surface that, in an embodiment, may be coated with materials or additives such as drugs, bone glue, proteins, growth factors, or other natural or synthetic coatings (for example, radiopaque or ultrasonically active materials). For example, after a minimally invasive surgical procedure an infection may develop in a patient, requiring the patient to undergo antibiotic treatment. An antibiotic drug may be added to the outer surface of the expandable portion to prevent or combat a possible infection. Proteins, such as, for example, bone morphogenic protein or other growth factors have been shown to induce the formation of cartilage and bone. A growth factor may be added to the outer surface of the expandable portion to help induce the formation of new bone. Due to the lack of thermal egress of the light-sensitive liquid in the expandable portion, the effectiveness and stability of the coating is maintained.


It should be understood that the expandable portions disclosed herein typically do not have any valves. One benefit of having no valves is that the expandable portion may be inflated or deflated as much as necessary to assist in the fracture reduction and placement. Another benefit of the expandable portion having no valves is the efficacy and safety of the system. Since there is no communication passage of light-sensitive liquid to the body there cannot be any leakage of liquid because all the liquid is contained within the expandable portion. In an embodiment, a permanent seal is created between the expandable portion that is both hardened and affixed prior to the insertion catheter being removed. The expandable portion may have valves, as all of the embodiments are not intended to be limited in this manner.


It should be understood that the expandable portions disclosed herein include an outer surface that is resilient and puncture resistant. In an embodiment, the outer surface of the expandable portion is substantially even and smooth. In an embodiment, the outer surface of the expandable portion is not entirely smooth and may have some small bumps or convexity/concavity along the length. In an embodiment, the outer surface of the expandable portion may have ribs, ridges, bumps or other shapes. In an embodiment, the expandable portion has a textured surface which provides one or more ridges that allow grabbing. In an embodiment, abrasively treating the outer surface of the expandable portion via chemical etching or air propelled abrasive media improves the connection and adhesion between the outer surface of the expandable portion and the bone. The surfacing significantly increases the amount of surface area that comes in contact with the bone resulting in a stronger grip.


One possible side effect of curing a light-sensitive liquid is polymerization shrinkage. The presently disclosed embodiments provide photodynamic bone stabilization systems sufficiently designed to control polymerization shrinkage that may occur in an expandable portion of the system during use. FIG. 2 shows a side view of an embodiment of a distal end 114 of the insertion catheter 101 of FIG. 1 of a photodynamic bone stabilization system of the present sufficiently designed to control polymerization shrinkage during use. The photodynamic bone stabilization system includes the flexible insertion catheter 101; an expandable portion 200 releasably engaging the distal end 114 of the insertion catheter 101, the expandable portion 200 sufficiently designed to move from a deflated state to an inflated state; and at least two ports located at the proximal end 112 of the insertion catheter 101, the ports sufficiently designed to attach with various co-components of the photodynamic bone stabilization system, including, but not limited to, a container or syringe for delivering a light-sensitive liquid through the insertion catheter 101 and up into the expandable portion 200, a light-conducting fiber for delivering light energy to expandable portion 200, and a syringe or hose for delivering air or other fluids to the expandable portion 200 to substantially prevent polymerization shrinkage.


The inner lumen 120 passes through the longitudinal axis of the flexible insertion catheter 101 and the expandable portion 200. The inner lumen 120 is sufficiently designed to pass a light-conducting fiber. The inner void 110 exists between an outer surface of the inner lumen 120 and an inner surface 130 of the insertion catheter 101; and an outer surface of the inner lumen 120 and an inner surface 230 of the expandable portion 200 and provides a passageway for light-sensitive liquid to travel.


During a procedure for repairing a weakened to fractured long bone, the expandable portion 200 is positioned between bone fragments and light-sensitive liquid is passed through the inner void 110 of the photodynamic bone stabilization system until it reaches the expandable portion 200 and begins to expand or inflate the expandable portion 200. The expandable portion 200 is inflated in situ with light-sensitive liquid to stabilize and reduce the fracture, which can optionally be performed under fluoroscopy. Because the light-sensitive liquid will not cure until illumination with light from the light-conducting fiber, the expandable portion 200 can be inflated and deflated as many times as needed in situ to insure the proper stabilization and reduction of the fracture. Once proper positioning of the expandable portion 200 is determined, the light-conducting fiber is positioned in the inner lumen 120 of the photodynamic bone stabilization system and activated, to deliver output energy to the expandable portion 200 which will polymerize or cure the light-sensitive liquid. There is the potential that during in situ curing of the light-sensitive liquid, areas of the expandable portion 200 that are not in the immediate vicinity of the polymerization process may exhibit polymerization shrinkage upon cure of about 2 to about 3 percent. This may be especially relevant when the expandable portion 200 is used to reduce and stabilize a long bone, where the expandable portion 200 may have a diameter ranging from about 13 mm to about 20 mm and a length ranging from about 100 mm to about 450 mm. To prevent shrinkage from occurring, the inner lumen 120 in the expandable portion 200 can be pressurized by virtue of the infusion of either air or other fluids (e.g., saline or water) to cause internal diameter pressure against the light-sensitive liquid contained within the expandable portion 200 so that during the curing, the pressure keeps the light-sensitive liquid pressurized, and up in contact with inner walls 230 of the expandable portion 200. In some embodiments, the inner lumen 120 in the expandable portion 200 is configured to include areas 224 which are capable of expanding when pressurized with air or other fluids.


In an embodiment, the inner lumen 120 in the expandable portion 200 includes one area 224 configured to prevent the effects of polymerization shrinkage during curing of the light-sensitive liquid. In an embodiment, the inner lumen 120 in the expandable portion 200 includes two areas 224 configured to prevent the effects of polymerization shrinkage during curing of the light-sensitive liquid. As illustrated in FIG. 2, the inner lumen 120 in the expandable portion 200 includes five areas 224 configured to prevent the effects of polymerization shrinkage during curing of the light-sensitive liquid. Depending on the length and the diameter of the expandable portion 200 used for a particular procedure, it is possible to determine how many areas 224 are required to prevent the effects of polymerization shrinkage during curing of the light-sensitive liquid.


One possible side effect of curing a light-sensitive liquid besides polymerization shrinkage is temperature rise. The temperature rise is in direct relation with the strength of polymerization light intensity. For instance, as intensity grows, so does the temperature. The presently disclosed embodiments provide photodynamic bone stabilization systems sufficiently designed to control temperature rise that may occur in an expandable portion of the system during use. In an embodiment, the photodynamic bone stabilization systems include an expandable portion sufficiently designed to move from a deflated state to an inflated state when a light-sensitive liquid is delivered to the expandable portion. Once proper positioning and expansion of the expandable portion is determined, the light-sensitive liquid can be cured in situ to harden the expandable portion thus providing a rigid orthopedic stabilizer. During use, there is the potential that the in situ curing process of the light-sensitive liquid can cause one or more areas of the expandable portion to experience a temperature rise. To prevent a temperature rise from occurring, a cooling medium can be delivered so as to cool the expandable portion during the curing process. Cooling medium for use with a photodynamic bone stabilization system of the present disclosure includes, but is not limited to, gases, liquids and combinations thereof. Examples of gases include, but are not limited to, inert gases and air. Examples of liquids include, but are not limited to, water, saline, saline-ice mixtures, liquid cryogen. In an embodiment, the cooling medium is water. The cooling medium can be delivered to the expandable portion at room temperature or at a cooled temperature. In an embodiment, the cooling medium improves the numerical aperture between that of the light-conducting fiber and the inner lumen for the light-conducting fiber because it is desirable to take up the air between the light-conducting fiber and the material of the expandable portion so as to improve light transmission. Therefore, the light transmission will be light-conducting fiber—cooling media—expandable portion—light-sensitive liquid as opposed to light-conducting fiber—air—expandable portion—light-sensitive liquid. In an embodiment, the cooling medium transmitted through the inner lumen takes away extraneous heat.



FIG. 3 shows a side view of an embodiment of a distal end 114 of the insertion catheter 101 of FIG. 1 of a photodynamic bone stabilization system of the present disclosure sufficiently designed to control temperature rise during use. The photodynamic bone stabilization system includes the flexible insertion catheter 101; an expandable portion 300 releasably engaging the distal end 114 of the insertion catheter 101, the expandable portion 300 sufficiently designed to move from a deflated state to an inflated state; and at least two ports located at the proximal end 112 of the insertion catheter 101, the ports sufficiently designed to attach with various co-components of the photodynamic bone stabilization system, including, but not limited to, a container or syringe for delivering a light-sensitive liquid through the insertion catheter 101 and up into the expandable portion 300, a light-conducting fiber for delivering light energy to expandable portion 300, and a syringe or hose for delivering cooling medium to the expandable portion 300.


In the embodiment illustrated in FIG. 3, the inner lumen 120 passes through the longitudinal axis of the flexible insertion catheter 101 and through a distal end 314 of the expandable portion 300. The inner lumen 120 is sufficiently designed to pass a light-conducting fiber, and is configured to pass a cooling medium. The inner void 110 exists between an outer surface of the inner lumen 120 and an inner surface 130 of the insertion catheter 101; and an outer surface of the inner lumen 120 and an inner surface 330 of the expandable portion 300 and provides a passageway for light-sensitive liquid to travel.


During a procedure for repairing a weakened to fractured long bone, the expandable portion 300 is positioned between bone fragments and light-sensitive liquid is passed through the inner void 110 of the photodynamic bone stabilization system until it reaches the expandable portion 300 and begins to expand or inflate the expandable portion 300. The expandable portion 300 is inflated in situ with light-sensitive liquid to stabilize and reduce the fracture, which can optionally be performed under fluoroscopy. Because the light-sensitive liquid will not cure until illumination with light from the light-conducting fiber, the expandable portion 300 can be inflated and deflated as many times as needed in situ to insure the proper stabilization and reduction of the fracture. Once proper positioning of the expandable portion 300 is determined, the light-conducting fiber is positioned in the inner lumen 120 of the photodynamic bone stabilization system and activated, to deliver output energy to the expandable portion 300 which will polymerize or cure the light-sensitive liquid. During use, there is the potential that the in situ curing process of the light-sensitive liquid can cause one or more areas of the expandable portion 300 to experience a temperature rise. To prevent a temperature rise from occurring, a cooling medium can be delivered through the inner lumen 120 concurrently with the light-conducting fiber, so as to cool the expandable portion 300 during the curing process.



FIG. 4 shows a side view of the expandable portion 300 of FIG. 3 after a light-sensitive liquid 315 has been added to the expandable portion 300. A light-conducting fiber 325 is introduced into the inner lumen 120 of the expandable portion 300 and activated to cure the light-sensitive liquid, while a cooling medium 328 flows through the inner lumen 120 and out the distal end 314 of the expandable portion 300.



FIGS. 5A-5D illustrate an embodiment of a procedure for repairing a weakened or fractured bone using the photodynamic bone stabilization system illustrated in FIG. 3. As illustrated in FIG. 5A, a procedure for repairing a weakened or fractured bone includes positioning the expandable portion 300 between bone fragments. In an embodiment, the expandable portion 300 spans multiple bone fragments. Once the expandable portion 300 is positioned, light-sensitive liquid monomer 315 is passed through the inner void 110 of the photodynamic bone stabilization system until it reaches the expandable portion 300 and begins to expand or inflate the expandable portion 300, as shown in FIG. 5B. The expandable portion 300 is inflated in situ with light-sensitive liquid monomer 315 to stabilize and reduce the fracture, which can optionally be performed under fluoroscopy. Because the light-sensitive liquid monomer 315 will not cure until illumination with light from the light-conducting fiber 325, the expandable portion 300 can be inflated and deflated as needed in situ to insure the proper stabilization and reduction of the fracture. Once proper positioning of the expandable portion 300 is determined, the light-conducting fiber 325 is introduced into the inner lumen 120 of the expandable portion 300 and activated, to deliver output energy to the expandable portion 300 which will polymerize or cure the light-sensitive liquid monomer, as shown in FIG. 5C. During use, there is the potential that the in situ curing process of the light-sensitive liquid monomer 315 can cause one or more areas of the expandable portion 300 to experience a temperature rise. As illustrated in FIG. 5C, to prevent a temperature rise from occurring, a cooling medium can be delivered through the lumen 120 of the expandable portion 300 to cool the expandable portion 300 during the curing process. In an embodiment, the cooling medium exits out the distal end 314 of the expandable portion 300 and collects or accumulates within the bone after exiting the expandable portion 300. FIG. 5D shows the hardened expandable portion 300 positioned within the weakened or fractured bone after the catheter 101 has been released.



FIG. 6 shows a side view of an embodiment of a distal end 114 of the insertion catheter 101 of FIG. 1 of a photodynamic bone stabilization system of the present disclosure sufficiently designed to control temperature rise during use. The photodynamic bone stabilization system includes the flexible insertion catheter 101; an expandable portion 500 releasably engaging the distal end 114 of the insertion catheter 101, the expandable portion 500 sufficiently designed to move from a deflated state to an inflated state; and at least two ports located at the proximal end 112 of the insertion catheter 101, the ports sufficiently designed to attach with various co-components of the photodynamic bone stabilization system, including, but not limited to, a container or syringe for delivering a light-sensitive liquid through the insertion catheter 101 and up into the expandable portion 500, a light-conducting fiber for delivering light energy to expandable portion 500, and a syringe or hose for delivering cooling medium to the expandable portion 300.


In the embodiment illustrated in FIG. 6, the inner lumen 120 passes through the longitudinal axis of the flexible insertion catheter 101 into the expandable portion 500. In an embodiment, the inner lumen 120 comprises a septum lumen 130 for passing the light-conducting fiber, the septum lumen 130 sufficiently designed to divide the inner lumen 120 into a cooling medium intake lumen 122 communicating with a cooling inlet and a cooling medium return lumen 124 communicating with a cooling outlet. In an embodiment, the inner lumen 120 is a return flow path for the cooling medium. The inner void 110 exists between an outer surface of the inner lumen 120 and an inner surface 530 of the insertion catheter 101; and an outer surface of the inner lumen 120 and an inner surface 530 of the expandable portion 500 and provides a passageway for light-sensitive liquid to travel.


During a procedure for repairing a weakened or fractured long bone, the expandable portion 500 is positioned between bone fragments and light-sensitive liquid is passed through the inner void 110 of the photodynamic bone stabilization system until it reaches the expandable portion 500 and begins to expand or inflate the expandable portion 500. The expandable portion 500 is inflated in situ with light-sensitive liquid to stabilize and reduce the fracture, which can optionally be performed under fluoroscopy. Because the light-sensitive liquid will not cure until illumination with light from the light-conducting fiber, the expandable portion 500 can be inflated and deflated as many times as needed in situ to insure the proper stabilization and reduction of the fracture. Once proper positioning of the expandable portion 500 is determined, the light-conducting fiber is positioned in the septum lumen 130 of the photodynamic bone stabilization system and activated, to deliver output energy to the expandable portion 500 which will polymerize or cure the light-sensitive liquid. During use, there is the potential that the in situ curing process of the light-sensitive liquid can cause one or more areas of the expandable portion 500 to experience a temperature rise. To prevent a temperature rise from occurring, a cooling medium can be delivered through the cooling medium intake lumen 122 so as to cool the expandable portion 500 during the curing process. The cooling medium is removed from the photodynamic bone stabilization system via the cooling medium return lumen 124.



FIG. 7 shows a side view of an embodiment of a distal end 114 of the insertion catheter 101 of FIG. 1 of a photodynamic bone stabilization system of the present disclosure sufficiently designed to control temperature rise during use. The photodynamic bone stabilization system includes the flexible insertion catheter 101; an expandable portion 600 releasably engaging the distal end 114 of the insertion catheter 101, the expandable portion 600 sufficiently designed to move from a deflated state to an inflated state; and at least two ports located at the proximal end 112 of the insertion catheter 101, the ports sufficiently designed to attach with various co-components of the photodynamic bone stabilization system, including, but not limited to, a container or syringe for delivering a light-sensitive liquid through the insertion catheter 101 and up into the expandable portion 600, a light-conducting fiber for delivering light energy to expandable portion 600, and a syringe or hose for delivering cooling medium to the expandable portion 600.


In the embodiment illustrated in FIG. 7, the inner lumen 120 (not visible in FIG. 7) passes through the longitudinal axis of the flexible insertion catheter 101 and into the expandable portion 600. The inner lumen 120 is sufficiently designed to pass a light-conducting fiber. The inner void 110 (not visible in FIG. 7) exists between an outer surface of the inner lumen 120 and an inner surface 130 (not visible in FIG. 7) of the insertion catheter 101; and an outer surface of the inner lumen 120 and an inner surface 630 (not visible in FIG. 7) of the expandable portion 600 and provides a passageway for light-sensitive liquid to travel. The expandable portion 600 includes external helical tubing 680 for providing cooling medium to the expandable portion 600.


During a procedure for repairing a weakened to fractured long bone, the expandable portion 600 is positioned between bone fragments and light-sensitive liquid is passed through the inner void 110 of the photodynamic bone stabilization system until it reaches the expandable portion 600 and begins to expand or inflate the expandable portion 600. The expandable portion 600 is inflated in situ with light-sensitive liquid to stabilize and reduce the fracture, which can optionally be performed under fluoroscopy. Because the light-sensitive liquid will not cure until illumination with light from the light-conducting fiber, the expandable portion 600 can be inflated and deflated as many times as needed in situ to insure the proper stabilization and reduction of the fracture. Once proper positioning of the expandable portion 600 is determined, the light-conducting fiber is positioned in the inner lumen 120 of the photodynamic bone stabilization system and activated, to deliver output energy to the expandable portion 600 which will polymerize or cure the light-sensitive liquid. During use, there is the potential that the in situ curing process of the light-sensitive liquid can cause one or more areas of the expandable portion 600 to experience a temperature rise. To prevent a temperature rise from occurring, a cooling medium can be delivered through the external helical tubing 680 so as to cool the expandable portion 600 from the outside during the curing process.


In an embodiment, a method for repairing a fractured bone in a patient using a photodynamic bone stabilization system sufficiently designed to control temperature rise that may occur during use includes: a minimally invasive incision is made through a skin of the patient to expose the fractured bone. The incision may be made at the proximal end or the distal end of the fractured bone to expose a bone surface. Once the bone surface is exposed, it may be necessary to retract some muscles and tissues that may be in view of the fractured bone. At least a first proximal access hole is formed in the fractured bone by drilling or other methods known in the art. The first proximal access hole extends through a hard compact outer layer of the fractured bone into the relatively porous inner or cancellous tissue. For bones with marrow, the medullary material should be cleared from the medullary cavity prior to insertion of the insertion catheter. Marrow is found mainly in the flat bones such as hip bone, breast bone, skull, ribs, vertebrae and shoulder blades, and in the cancellous material at the proximal ends of the long bones like the femur and humerus. Once the medullary cavity is reached, the medullary material including air, blood, fluids, fat, marrow, tissue and bone debris should be removed to form a void. The void is defined as a hollowed out space, wherein a first position defines the most distal edge of the void with relation to the penetration point on the bone, and a second position defines the most proximal edge of the void with relation to the penetration site on the bone. The bone may be hollowed out sufficiently to have the medullary material of the medullary cavity up to the cortical bone removed. In an embodiment, such as when the expandable portion 300 of FIG. 3 is used, a second distal access hole is formed in the fractured bone. The second distal access hole is created such that the cooling medium pooling out of the distal end 314 of the expandable portion 300 can be collected. An introducer sheath may be introduced into the bone via the first access hole and placed between bone fragments of the bone to cross the location of a fracture. The introducer sheath may be delivered into the lumen of the bone and crosses the location of the break so that the introducer sheath spans multiple sections of bone fragments. The expandable portion of the insertion catheter, is delivered through the introducer sheath to the site of the fracture and spans the bone fragments of the bone. Once the expandable portion is in place, the guidewire may be removed. The location of the expandable portion may be determined using at least one radiopaque marker which is detectable from the outside or the inside of the bone. Once the expandable portion is in the correct position within the fractured bone, the introducer sheath may be removed. A delivery system housing a light-sensitive liquid is attached to the proximal end of the insertion catheter. The light-sensitive liquid is then infused through an inner void in the insertion catheter and enters the expandable portion. This addition of the light-sensitive liquid within the expandable portion causes the expandable portion to expand. As the expandable portion is expanded, the fracture is reduced.


Once orientation of the bone fragments are confirmed to be in a desired position, the light-sensitive liquid may be cured within the expandable portion, such as by illumination with a visible emitting light source. In an embodiment, visible light having a wavelength spectrum of between about 380 nm to about 780 nm, between about 400 nm to about 600 nm, between about 420 nm to about 500 nm, between about 430 nm to about 440 nm, is used to cure the light-sensitive liquid. In an embodiment, the addition of the light causes the photoinitiator in the light-sensitive liquid, to initiate the polymerization process: monomers and oligomers join together to form a durable biocompatible crosslinked polymer. In an embodiment, the cure provides complete 360 degree radial and longitudinal support and stabilization to the fractured bone. During this curing, a syringe housing the cooling medium is attached to the proximal end of the insertion catheter and continuously delivered to the expandable portion. When the expandable portion 300 of FIG. 3 is used, the cooling medium can be collected by connecting tubing to the distal end 314 of the expandable portion 300 and collecting the cooling medium via the second distal access hole. After the light-sensitive liquid has been hardened, the light-conducting fiber can be removed from the insertion catheter. The expandable portion once hardened, may be released from the insertion catheter. The hardened expandable portion remains in the fractured bone, and the insertion catheter is removed. In an embodiment, the outer surface of the hardened expandable portion makes contact with the cortical bone.


In an embodiment, a photodynamic bone stabilization system of the present disclosure is sufficiently designed to selectively stiffen an expandable portion of the system during use. In an embodiment, a photodynamic bone stabilization system of the present disclosure includes an expandable portion having a plurality of stiffening members. In an embodiment, the plurality of stiffening members are disposed along the length of the expandable portion. In an embodiment, the plurality of stiffening members are disposed along the length of an outer surface of the expandable portion. In an embodiment, the plurality of stiffening members are disposed along the length of an inner surface of the expandable portion. The stiffening members can be secured to the expandable portion in a variety of ways. For example and not limitation, the stiffening members can be secured to an adapter, e.g., luer, hub, manifold, or a reinforcement or filler material, or support member. Alternatively, the stiffening members can be secured to the expandable portion by way of an engagement member. In this manner, an engagement member can be secured to the surface of the expandable portion such that a space or cavity is defined for engaging the stiffening members. In an embodiment, the expandable portion includes a plurality of stiffening members configured to control or vary axial flexibility along a length of the expandable portion. In an embodiment, the expandable portion includes a plurality of stiffening members that can be disposed radially and/or axially.



FIG. 8A, FIG. 8B, FIG. 9A, FIG. 9B, FIG. 10A, FIG. 10B, FIG. 11A, FIG. 11B, and FIG. 12A show various embodiments of a distal end 114 of the insertion catheter 101 of FIG. 1 of a photodynamic bone stabilization system of the present disclosure sufficiently designed to control or vary axial flexibility along a length of the expandable portion. In such embodiments, a stiffness of the expandable portion has been increased due to the presence of an external stiffening member(s) (see FIG. 8A, FIG. 8B, FIG. 9A, FIG. 9B and FIG. 12A) or an internal stiffening member(s) (see FIG. 10A, FIG. 10B, FIG. 11A and FIG. 11B). In an embodiment, the expandable portion includes internal stiffening member(s). In an embodiment, the expandable portion includes external stiffening member(s). In an embodiment, the expandable portion includes a combination of internal stiffening member(s) and external stiffening member(s). In an embodiment, external and internal stiffening member(s) can be made from metal materials such as, for example, Nitonol or metallic memory-type metal pieces. In an embodiment, the stiffening member(s) or metallic pieces may be of any size or geometric shape desirable.


In an embodiment, the stiffening members or metallic pieces may protrude or extend from the expandable portion such that the metallic pieces extend beyond the diameter of the expandable portion. In an embodiment, stiffening members or metallic pieces may be situated within the expandable portion such that the diameter of the expandable portion may be substantially maintained. In an embodiment, stiffening members or metallic pieces may be integral with the expandable portion such that the expandable portion and the stiffening members are contiguous with one another. In an embodiment, stiffening members or metallic pieces may be attached, coupled, covered, sheathed, or otherwise connected to the expandable portion. In an embodiment, the stiffening members or metallic pieces may be contiguous with one another so as to form one structure around the expandable portion. In an embodiment, the stiffening members or metallic pieces can be separate and distinct so as to form multiple structures around the expandable portion. In an embodiment, the stiffening members or metallic pieces are circumferentially connected to one another at a distal end and a proximal end forming end plates. In an embodiment, the end plates help maintain the structure of the stiffening members or metallic pieces when the expandable portion is expanded.


In an embodiment, the stiffening members or metallic pieces may alter or change their configuration under a temperature change. In an embodiment, the metallic pieces expand outwards against the bone at the site of fracture. In an embodiment, the metallic pieces can expand to increase the strength of the hardened expandable potion. In an embodiment, the metallic pieces can contract to increase the strength of the hardened expandable potion. In an embodiment, an inner surface of the metallic pieces (those surfaces that are in contact with the external circumferential surface of the expandable portion) are polished to increase internal reflection of the light from the light-conducting fiber. In an embodiment, the metallic pieces are sufficiently designed to be load-bearing shapes. In an embodiment, the metallic pieces have a low profile and can handle large loads. In an embodiment, the metallic pieces may produce a greater amount of force on a large area than a small area. In an embodiment, the metallic pieces may produce a greater amount of force in a tight or narrow space that in a shallow or open space.


As illustrated in the embodiments of FIG. 8A and FIG. 8B and FIG. 9A and FIG. 9B, metallic pieces 750 and 850, respectively, are positioned on the external circumferential surface of an expandable portion 700 and 800, respectively. The metallic pieces 750 and 850 can be aligned in a longitudinal fashion, circumferentially around the expandable portion 700 (FIG. 8A and FIG. 8B) and can be interconnected with one another via connecting means 860 such as wires (FIG. 9A and FIG. 9B). The wires 860 will help hold the longitudinal metallic pieces 850 in position. The number and placement of the wires 860 can vary depending on a desired outcome. In an embodiment, the metallic pieces expand to increase the strength of the hardened expandable potion. In an embodiment, the metallic pieces contract to increase the strength of the hardened expandable potion. In an embodiment, metallic pieces 950 are positioned on an internal circumferential surface of an expandable portion 900 (FIG. 10A and FIG. 10B).


In an embodiment, two metallic memory-type metal wires 1050, such as nitonol, are positioned within the expandable portion 500 from FIG. 6 (FIG. 11A and FIG. 11B). Heat from a light-conducting fiber makes the metal wires 1050 get smaller, tensioning the hardened expandable portion 500. In an embodiment, an expandable portion 1100 is wrapped with a plurality of flat metallic plates 1150 that move into a corrugated or other shape upon a temperature change to increase the strength of the previously flat metal plate 1150 into a shape capable of handling a load (FIG. 12A). In an embodiment, the metals are rectangular, semicircular, hexagonal, or triangular in section, although not all embodiments are limited to these shapes (FIGS. 12B-12G).


The present disclosure provides photodynamic bone stabilization systems and methods for reinforcing bone. In an embodiment, a photodynamic bone stabilization system of the present disclosure is sufficiently designed to control polymerization shrinkage that may occur in an expandable portion of the system during use. In an embodiment, a photodynamic bone stabilization system of the present disclosure is sufficiently designed to control temperature rise that may occur in an expandable portion of the system during use. In an embodiment, a photodynamic bone stabilization system of the present disclosure is sufficiently designed to selectively stiffen an expandable portion of the system during use. It should be understood that the benefits provided by each of the photodynamic bone stabilization systems disclosed herein, including means to control polymerization shrinkage, means to control temperature rise, and means to selectively stiffen, can be used alone or combination. For example, in an embodiment, a photodynamic bone stabilization system of the present disclosure includes means for both controlling polymerization shrinkage and for controlling temperature rise. In an embodiment, a photodynamic bone stabilization system of the present disclosure includes means for both controlling temperature rise and means to selectively stiffen (as disclosed FIG. 11 and FIG. 12). In an embodiment, a photodynamic bone stabilization system of the present disclosure includes means for controlling polymerization shrinkage, means for controlling temperature rise, and means to selectively stiffen.


In an embodiment, a photodynamic bone stabilization system includes an insertion catheter having an elongated shaft with a proximal end, a distal end, and a longitudinal axis therebetween, the insertion catheter having an inner void for passing a light-sensitive liquid, an inner lumen for accepting a light-conducting fiber, and a pathway sufficiently designed for passing a cooling medium; an expandable portion releasably engaging the distal end of the insertion catheter, the expandable portion moving from a deflated state to an inflated state when the light-sensitive liquid is delivered to the expandable portion; and adapters releasably engaging the proximal end of the insertion catheter for receiving the light-conducting fiber, the light-sensitive liquid, and the cooling medium.


In an embodiment, a photodynamic bone stabilization system includes an insertion catheter having an elongated shaft with a proximal end, a distal end, and a longitudinal axis therebetween, the insertion catheter having an inner void for passing a light-sensitive liquid, and an inner lumen for accepting a light-conducting fiber, the inner lumen sufficiently designed to be pressurized by virtue of infusion of air, fluid, or combinations thereof; an expandable portion releasably engaging the distal end of the insertion catheter, the expandable portion moving from a deflated state to an inflated state when the light-sensitive liquid is delivered to the expandable portion; and adapters releasably engaging the proximal end of the insertion catheter for receiving the light-conducting fiber, the light-sensitive liquid, and the air or fluid, wherein the infusion of the air or fluid causes internal diameter pressure against the light-sensitive liquid contained within the expandable portion so that during a curing process, pressure keeps the light-sensitive liquid pressurized, and up in contact with inner walls of the expandable portion.


In an embodiment, a photodynamic bone stabilization system includes an insertion catheter having an elongated shaft with a proximal end, a distal end, and a longitudinal axis therebetween, the insertion catheter having an inner void for passing a light-sensitive liquid, and an inner lumen for accepting a light-conducting fiber; an expandable portion releasably engaging the distal end of the insertion catheter, the expandable portion moving from a deflated state to an inflated state when the light-sensitive liquid is delivered to the expandable portion; stiffening members engaging the expandable portion; and adapters releasably engaging the proximal end of the insertion catheter for receiving the light-conducting fiber and the light-sensitive liquid.


In an embodiment, a photodynamic bone stabilization system includes a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween; a light-conducting fiber configured to transmit light energy to the expandable portion; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy to initiate polymerization of the light-sensitive liquid monomer; and a cooling medium configured to control polymerization temperature, wherein the catheter comprises an inner void sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, and wherein the catheter comprises an inner lumen sufficiently designed to pass the light-conducting fiber into the expandable portion and configured to circulate the cooling medium.


In an embodiment, a photodynamic bone stabilization system includes a light-conducting fiber configured to transmit light energy; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy; a pressurizing medium configured to control polymerization shrinkage; and a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween, wherein the catheter comprises an inner void and an inner lumen, wherein the inner void is sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, wherein the inner lumen is sufficiently designed to pass the light-conducting fiber into the expandable portion, and wherein the inner lumen comprises expandable portions configured to expand when the pressurizing medium is delivered to the inner lumen so as to cause internal diameter pressure against the light-sensitive liquid monomer contained within the expandable portion during polymerization.


In an embodiment, a method includes providing a system comprising a catheter having an elongated shaft with a proximal end adapter, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween; a light-conducting fiber configured to transmit light energy to the expandable portion; a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy, to initiate polymerization of the light-sensitive liquid monomer; and a cooling medium configured to control polymerization temperature, wherein the catheter comprises an inner void sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion, and wherein the catheter comprises an inner lumen sufficiently designed to pass the light-conducting fiber into the expandable portion and configured to circulate the cooling medium; inserting the expandable portion of the system into an intramedullary canal spanning a fracture site comprising a plurality of fractured pieces; infusing the light-sensitive liquid monomer into the inner void of the catheter so that the light-sensitive liquid monomer expands the expandable portion until the fractured pieces are substantially restored to their natural positions; inserting the light-conducting fiber into the inner lumen of the catheter so that the light-conducting fiber resides in the expandable portion; activating the light-conducting fiber to transmit light energy to the expandable portion to initiate in situ polymerization of the light-sensitive liquid monomer within the expandable portion; infusing the cooling medium into the inner lumen of the catheter to control polymerization temperature; and completing the in situ polymerization of the light-sensitive liquid monomer to harden the expandable portion at the fracture site.


All patents, patent applications, and published references cited herein are hereby incorporated by reference in their entirety. It will be appreciated that several of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or application. Various presently unforeseen or unanticipated alternatives, modifications, variations, or improvements therein may be subsequently made by those skilled in the art.

Claims
  • 1. A photodynamic bone stabilization system comprising: a catheter having an elongated shaft with a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween;a light-conducting fiber configured to transmit light energy into the expandable portion;a light-sensitive liquid monomer comprising an initiator within the expandable portion, wherein the initiator is activated when the light-conducting fiber transmits the light energy for polymerization of the light-sensitive liquid monomer; anda cooling medium configured to control polymerization,
  • 2. The system of claim 1 wherein the catheter further comprises a proximal end adapter, wherein the proximal end adapter comprises: a first adapter for infusion of the light-sensitive liquid;a second adapter for infusion of the cooling medium; anda third adapter for introduction of the light-conducting fiber.
  • 3. The system of claim 1 wherein the expandable portion is fabricated from a thin-walled, non-compliant PET nylon aramet.
  • 4. The system of claim 1 wherein the cooling medium is one of saline or water.
  • 5. The system of claim 1 wherein the light-conducting fiber is an optical fiber.
  • 6. The system of claim 1 wherein at least a portion of the inner lumen in the expandable portion is expandable when pressurized with air or other fluids, the expandable portions configured to prevent effects of polymerization shrinkage during curing of the light-sensitive liquid.
  • 7. The system of claim 1 wherein the expandable portion includes stiffening members for selectively stiffening the expandable portion.
  • 8. The system of claim 7 wherein the stiffening members are positioned radially around an outside surface of the expandable portion.
  • 9. The system of claim 7 wherein the stiffening members are positioned radially around an inner surface of the expandable portion.
  • 10. The system of claim 7 wherein the stiffening members are fabricated from metallic memory-type metal pieces.
  • 11. The system of claim 1 wherein the inner lumen passes through a distal end of the expandable portion.
  • 12. The system of claim 1 wherein the inner lumen comprises a cooling medium intake lumen and a cooling medium return lumen.
  • 13. A photodynamic bone stabilization system comprising: a light-conducting fiber configured to transmit light energy;a light-sensitive liquid monomer comprising an initiator, wherein the initiator is activated when the light-conducting fiber transmits the light energy to initiate polymerization of the light-sensitive liquid monomer;a pressurizing medium configured to control polymerization shrinkage; anda catheter having an elongated shaft, a distal end releasably engaging an expandable portion, and a longitudinal axis therebetween, wherein the catheter comprises an inner void and an inner lumen, wherein the inner void is sufficiently designed to pass the light-sensitive liquid monomer into the expandable portion,wherein the inner lumen is sufficiently designed to pass the light-conducting fiber into the expandable portion, andwherein the inner lumen in the expandable portion comprises at least two separate areas configured to expand when the pressurizing medium is delivered to the inner lumen in the expandable portion so as to cause internal diameter pressure against the light-sensitive liquid monomer contained within the expandable portion during polymerization.
  • 14. The system of claim 13 further comprising: a cooling medium configured to control polymerization temperature of the expandable portion.
  • 15. A method comprising: inserting an expandable portion of a photodynamic bone stabilization system into an intramedullary canal spanning a bone fracture site comprising a plurality of fractured bone pieces, wherein the photodynamic bone stabilization system comprises: a catheter having a distal end releasably engaging the expandable portion, an inner void, and an inner lumen extending longitudinally within the catheter into the expandable portion, wherein a septum lumen divides the inner lumen into a cooling medium intake lumen and a cooling lumen return lumen;infusing a light-sensitive liquid monomer into the inner void of the catheter so that the light-sensitive liquid monomer expands the expandable portion until the fractured pieces are substantially restored to their natural positions;inserting a light-conducting fiber into the septum lumen of the catheter so that the light-conducting fiber resides in the expandable portion, wherein the light-conducting fiber is configured to transmit light energy to the expandable portion;activating the light-conducting fiber to transmit light energy to the expandable portion to initiate polymerization of the light-sensitive liquid monomer within the expandable portion;delivering a pressurizing medium to the inner lumen of the catheter;infusing a cooling medium into the cooling medium intake lumen of the catheter to control polymerization temperature; andcompleting the polymerization of the light-sensitive liquid monomer to harden the expandable portion at the bone fracture site,wherein the inner lumen in the expandable portion comprises at least two separate areas configured to expand when the pressurizing medium is delivered to the inner lumen to cause internal diameter pressure against the light-sensitive liquid monomer contained within the expandable portion during polymerization.
  • 16. The method of claim 15 further comprising removing the light-conducting fiber from the catheter.
  • 17. The method of claim 15 further comprising releasing the expandable portion from the catheter.
  • 18. The method of claim 15 wherein the hardened expandable portion stabilizes the bone fracture site.
  • 19. The method of claim 15 wherein the hardened expandable portion maintains the positions of the plurality of fractured bone pieces while the bone heals.
  • 20. The method of claim 15 wherein the hardened expandable portion immobilizes joints above and below the fracture site.
RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 12/755,784, filed on Apr. 7, 2010, which claims priority to and the benefit of U.S. Provisional Patent Application No. 61/167,276, filed on Apr. 7, 2009, the entireties of all these applications are hereby incorporated herein by reference.

US Referenced Citations (353)
Number Name Date Kind
4280233 Raab Jul 1981 A
4294251 Greenwald et al. Oct 1981 A
4313434 Segal Feb 1982 A
4341691 Anuta Jul 1982 A
4369772 Miller Jan 1983 A
4414608 Furihata Nov 1983 A
4422719 Orcutt Dec 1983 A
4433898 Nasiri Feb 1984 A
4462394 Jacobs Jul 1984 A
4466435 Murray Aug 1984 A
4562598 Kranz Jan 1986 A
4686973 Frisch Aug 1987 A
4697584 Haynes Oct 1987 A
4735625 Davidson Apr 1988 A
4870953 DonMicheal et al. Oct 1989 A
4888024 Powlan Dec 1989 A
4904391 Freeman Feb 1990 A
4961424 Kubota et al. Oct 1990 A
4963151 Ducheyne et al. Oct 1990 A
4969888 Scholten et al. Nov 1990 A
5030093 Mitnick Jul 1991 A
5049157 Mittelmeier et al. Sep 1991 A
5085660 Lin Feb 1992 A
5092899 Forte Mar 1992 A
5102413 Poddar Apr 1992 A
5108404 Scholten et al. Apr 1992 A
5112333 Fixel May 1992 A
5295733 LeBegue Mar 1994 A
5295962 Crocker et al. Mar 1994 A
5303718 Krajicek Apr 1994 A
5316550 Forte May 1994 A
5336699 Cooke et al. Aug 1994 A
5372598 Luhr et al. Dec 1994 A
5391144 Sakurai et al. Feb 1995 A
5415654 Daikuzono May 1995 A
5423850 Berger Jun 1995 A
5432876 Appeldorn et al. Jul 1995 A
5443468 Johnson Aug 1995 A
5462552 Kiester Oct 1995 A
5480400 Berger Jan 1996 A
5538514 Hawkins Jul 1996 A
5548676 Savage, Jr. Aug 1996 A
5554111 Morrey et al. Sep 1996 A
5556429 Felt Sep 1996 A
5571204 Nies Nov 1996 A
5658310 Berger Aug 1997 A
5658963 Qian et al. Aug 1997 A
5705181 Cooper et al. Jan 1998 A
5707374 Schmidt Jan 1998 A
5713901 Tock Feb 1998 A
5795353 Felt Aug 1998 A
5824087 Aspden et al. Oct 1998 A
5827289 Reiley et al. Oct 1998 A
5888220 Felt et al. Mar 1999 A
5897557 Chin et al. Apr 1999 A
5908433 Eager et al. Jun 1999 A
5972015 Scribner et al. Oct 1999 A
5980075 Sheaffer Nov 1999 A
5980253 Oxman et al. Nov 1999 A
5987199 Zarian et al. Nov 1999 A
5989230 Frassica Nov 1999 A
6008264 Ostler et al. Dec 1999 A
6019761 Gustilo Feb 2000 A
6019774 Weiss et al. Feb 2000 A
6033411 Preissman Mar 2000 A
6039762 McKay Mar 2000 A
6042380 De Rowe Mar 2000 A
6048346 Reiley et al. Apr 2000 A
6059789 Dinger et al. May 2000 A
6066154 Reiley et al. May 2000 A
6079868 Rydell Jun 2000 A
6103203 Fischer Aug 2000 A
6110176 Shapira Aug 2000 A
6121341 Sawhney et al. Sep 2000 A
6127597 Beyar et al. Oct 2000 A
6140452 Felt et al. Oct 2000 A
6159236 Biel Dec 2000 A
6179852 Strickland et al. Jan 2001 B1
6195477 Denuto et al. Feb 2001 B1
6200134 Kovac et al. Mar 2001 B1
6217581 Tolson Apr 2001 B1
6223085 Dann et al. Apr 2001 B1
6224630 Bao et al. May 2001 B1
6235043 Reiley et al. May 2001 B1
6241734 Scribner et al. Jun 2001 B1
6248110 Reiley et al. Jun 2001 B1
6248131 Felt et al. Jun 2001 B1
6258089 Campbell et al. Jul 2001 B1
6261289 Levy Jul 2001 B1
6280456 Scribner et al. Aug 2001 B1
6282013 Ostler et al. Aug 2001 B1
6290382 Bourn et al. Sep 2001 B1
6299597 Buscemi et al. Oct 2001 B1
6306177 Felt et al. Oct 2001 B1
6319255 Grundei et al. Nov 2001 B1
6332894 Stalcup et al. Dec 2001 B1
6336914 Gillespie, III Jan 2002 B1
6336930 Stalcup et al. Jan 2002 B1
6358252 Shapira Mar 2002 B1
6387098 Cole et al. May 2002 B1
6395007 Bhatnagar et al. May 2002 B1
6416531 Chen Jul 2002 B2
6416737 Manolagas et al. Jul 2002 B1
6419483 Adam et al. Jul 2002 B1
6423083 Reiley et al. Jul 2002 B2
6425923 Stalcup et al. Jul 2002 B1
6440444 Boyce et al. Aug 2002 B2
6443988 Felt et al. Sep 2002 B2
6447514 Stalcup et al. Sep 2002 B1
6458375 Gertzman et al. Oct 2002 B1
6478751 Krueger et al. Nov 2002 B1
6485512 Cheng Nov 2002 B1
6494883 Ferree Dec 2002 B1
6524251 Rabiner et al. Feb 2003 B2
6524313 Fassier et al. Feb 2003 B1
6551321 Burkinshaw et al. Apr 2003 B1
6551337 Rabiner et al. Apr 2003 B1
6565528 Mueller May 2003 B1
6579277 Rabiner et al. Jun 2003 B1
6579279 Rabiner et al. Jun 2003 B1
6620185 Harvie et al. Sep 2003 B1
6623505 Scribner et al. Sep 2003 B2
6632235 Weikel et al. Oct 2003 B2
6648881 KenKnight et al. Nov 2003 B2
6652547 Rabiner et al. Nov 2003 B2
6652587 Felt et al. Nov 2003 B2
6660013 Rabiner et al. Dec 2003 B2
6679873 Rabiner et al. Jan 2004 B2
6695781 Rabiner et al. Feb 2004 B2
6695782 Rabiner et al. Feb 2004 B2
6696073 Boyce et al. Feb 2004 B2
6716216 Boucher et al. Apr 2004 B1
6719773 Boucher et al. Apr 2004 B1
6726691 Osorio et al. Apr 2004 B2
6730048 Hare et al. May 2004 B1
6733451 Rabiner et al. May 2004 B2
6733513 Boyle et al. May 2004 B2
6740093 Hochschuler et al. May 2004 B2
6755862 Keynan Jun 2004 B2
6783530 Levy Aug 2004 B1
6802835 Rabiner et al. Oct 2004 B2
6818018 Sawhney Nov 2004 B1
6852095 Ray Feb 2005 B1
6866678 Shenderova et al. Mar 2005 B2
6869442 Cheng Mar 2005 B2
6875212 Shaolian et al. Apr 2005 B2
6885246 Tsutsui et al. Apr 2005 B2
6887246 Bhatnagar et al. May 2005 B2
6887275 Carchidi et al. May 2005 B2
6899713 Shaolian et al. May 2005 B2
6899719 Reiley et al. May 2005 B2
6932843 Smith et al. Aug 2005 B2
6964667 Shaolian et al. Nov 2005 B2
6979341 Scribner et al. Dec 2005 B2
6981981 Reiley et al. Jan 2006 B2
7001431 Bao et al. Feb 2006 B2
7008433 Voellmicke et al. Mar 2006 B2
7052498 Levy et al. May 2006 B2
7077865 Bao et al. Jul 2006 B2
7124067 Ascenzi Oct 2006 B2
7141061 Williams et al. Nov 2006 B2
7144414 Harvie et al. Dec 2006 B2
7153305 Johnson et al. Dec 2006 B2
7156861 Scribner et al. Jan 2007 B2
7156880 Evans et al. Jan 2007 B2
7169140 Kume Jan 2007 B1
7215863 Arenella et al. May 2007 B1
7241303 Reiss et al. Jul 2007 B2
7258692 Thelen et al. Aug 2007 B2
7261720 Stevens et al. Aug 2007 B2
7320709 Felt et al. Jan 2008 B2
7341601 Eisermann et al. Mar 2008 B2
7360542 Nelson et al. Apr 2008 B2
7407616 Melikechi et al. Aug 2008 B2
7419450 Ito Sep 2008 B2
7427295 Ellman et al. Sep 2008 B2
7547319 Segal et al. Jun 2009 B2
7628800 Sherman et al. Dec 2009 B2
7632277 Woll et al. Dec 2009 B2
7632291 Stephens et al. Dec 2009 B2
7666205 Weikel et al. Feb 2010 B2
7722620 Truckai et al. May 2010 B2
7744555 DiMauro et al. Jun 2010 B2
7766965 Bao et al. Aug 2010 B2
7771476 Justis et al. Aug 2010 B2
7776075 Bruneau et al. Aug 2010 B2
7806900 Rabiner Oct 2010 B2
7811284 Rabiner Oct 2010 B2
7811286 Medoff Oct 2010 B2
7811290 Rabiner Oct 2010 B2
7842040 Rabiner et al. Nov 2010 B2
7850711 Stone et al. Dec 2010 B1
7879041 Rabiner et al. Feb 2011 B2
7912539 Doty et al. Mar 2011 B2
7947015 Herweck et al. May 2011 B2
8034071 Scribner et al. Oct 2011 B2
8123807 Kim Feb 2012 B2
8210729 O'Leary et al. Jul 2012 B2
8246628 Rabiner Aug 2012 B2
8328402 O'Leary et al. Dec 2012 B2
8348956 Rabiner Jan 2013 B2
8366711 Rabiner et al. Feb 2013 B2
8403968 Rabiner et al. Mar 2013 B2
8512338 Rabiner et al. Aug 2013 B2
20010011174 Reiley et al. Aug 2001 A1
20010044626 Reiley et al. Nov 2001 A1
20020156482 Scribner et al. Oct 2002 A1
20020161373 Osorio et al. Oct 2002 A1
20020198526 Shaolian et al. Dec 2002 A1
20030028210 Boyle et al. Feb 2003 A1
20030083642 Boyd et al. May 2003 A1
20030105469 Karmon Jun 2003 A1
20030114914 Cheng Jun 2003 A1
20030156431 Gozum et al. Aug 2003 A1
20030199850 Chavez et al. Oct 2003 A1
20030212426 Olson et al. Nov 2003 A1
20030229372 Reiley et al. Dec 2003 A1
20040006341 Shaolian et al. Jan 2004 A1
20040024388 Altshuler Feb 2004 A1
20040034434 Evans et al. Feb 2004 A1
20040059333 Carl et al. Mar 2004 A1
20040059417 Smith et al. Mar 2004 A1
20040092948 Stevens et al. May 2004 A1
20040098015 Weikel et al. May 2004 A1
20040117025 Reindel Jun 2004 A1
20040133280 Trieu Jul 2004 A1
20040167561 Boucher et al. Aug 2004 A1
20040167625 Beyar et al. Aug 2004 A1
20040225296 Reiss et al. Nov 2004 A1
20040228142 Takada et al. Nov 2004 A1
20040230309 Di Mauro et al. Nov 2004 A1
20040247641 Felt et al. Dec 2004 A1
20050010231 Myers Jan 2005 A1
20050015140 deBeer Jan 2005 A1
20050015148 Jansen et al. Jan 2005 A1
20050043733 Eisermann et al. Feb 2005 A1
20050043808 Felt et al. Feb 2005 A1
20050049691 Mericle et al. Mar 2005 A1
20050090901 Studer Apr 2005 A1
20050119662 Reiley et al. Jun 2005 A1
20050142315 DeSimone et al. Jun 2005 A1
20050149022 Shaolian et al. Jul 2005 A1
20050159749 Levy et al. Jul 2005 A1
20050171604 Michalow Aug 2005 A1
20050192671 Bao et al. Sep 2005 A1
20050197711 Cachia Sep 2005 A1
20050228260 Burwell et al. Oct 2005 A1
20050234453 Shaolian et al. Oct 2005 A1
20050251140 Shaolian et al. Nov 2005 A1
20050284485 Nelson et al. Dec 2005 A9
20060009550 Messersmith et al. Jan 2006 A1
20060015105 Warren et al. Jan 2006 A1
20060036253 Leroux et al. Feb 2006 A1
20060084985 Kim et al. Apr 2006 A1
20060100547 Rabiner et al. May 2006 A1
20060100635 Reiley et al. May 2006 A1
20060100706 Shadduck et al. May 2006 A1
20060111726 Felt et al. May 2006 A1
20060122625 Truckai et al. Jun 2006 A1
20060155296 Richter Jul 2006 A1
20060173464 Ellman et al. Aug 2006 A1
20060183811 Melikechi et al. Aug 2006 A1
20060184246 Zwirkoski Aug 2006 A1
20060195165 Gertner et al. Aug 2006 A1
20060217747 Ferree Sep 2006 A1
20060229617 Meller et al. Oct 2006 A1
20060247787 Rydell et al. Nov 2006 A1
20060253102 Nance et al. Nov 2006 A1
20060253200 Bao et al. Nov 2006 A1
20060258981 Eidenschink Nov 2006 A1
20060264950 Nelson et al. Nov 2006 A1
20060264951 Nelson et al. Nov 2006 A1
20060264952 Nelson et al. Nov 2006 A1
20060265077 Zwirkoski Nov 2006 A1
20060271061 Beyar et al. Nov 2006 A1
20060276793 Berry Dec 2006 A1
20060276819 Osorio et al. Dec 2006 A1
20060282169 Felt et al. Dec 2006 A1
20060287730 Segal et al. Dec 2006 A1
20070027547 Rydell et al. Feb 2007 A1
20070067032 Felt et al. Mar 2007 A1
20070087031 Ashman et al. Apr 2007 A1
20070118143 Ralph et al. May 2007 A1
20070123876 Czartoski et al. May 2007 A1
20070123877 Goldin et al. May 2007 A1
20070123878 Shaver et al. May 2007 A1
20070161991 Altarac et al. Jul 2007 A1
20070198023 Sand et al. Aug 2007 A1
20070225705 Osario et al. Sep 2007 A1
20070255287 Rabiner Nov 2007 A1
20080015500 Herweck et al. Jan 2008 A1
20080021474 Bonutti et al. Jan 2008 A1
20080039854 Rabiner Feb 2008 A1
20080080205 Forrester et al. Apr 2008 A1
20080103505 Fransen May 2008 A1
20080125784 Rabiner et al. May 2008 A1
20080154368 Justis et al. Jun 2008 A1
20080154373 Protopsaltis et al. Jun 2008 A1
20080183122 Fisher et al. Jul 2008 A1
20080188858 Luzzi et al. Aug 2008 A1
20080234820 Felt et al. Sep 2008 A1
20080249529 Zarda et al. Oct 2008 A1
20080255560 Myers et al. Oct 2008 A1
20080269750 Justin Oct 2008 A1
20080287951 Stoneburner et al. Nov 2008 A1
20090018524 Greenhalgh et al. Jan 2009 A1
20090024166 Carl et al. Jan 2009 A1
20090048629 Rabiner Feb 2009 A1
20090054900 Rabiner et al. Feb 2009 A1
20090093887 Walter et al. Apr 2009 A1
20090112196 Rabiner et al. Apr 2009 A1
20090171265 Doty et al. Jul 2009 A1
20090171358 Chang et al. Jul 2009 A1
20090177204 Colleran et al. Jul 2009 A1
20090182336 Brenzel et al. Jul 2009 A1
20090187192 Rabiner et al. Jul 2009 A1
20090216232 Buford, III et al. Aug 2009 A1
20090228007 Justin et al. Sep 2009 A1
20090254064 Boatman Oct 2009 A1
20090287309 Walch et al. Nov 2009 A1
20100234958 Linares Sep 2010 A1
20100249942 Goswami et al. Sep 2010 A1
20100256641 Rabiner et al. Oct 2010 A1
20100262069 Rabiner et al. Oct 2010 A1
20100262188 Rabiner et al. Oct 2010 A1
20100265733 O'Leary et al. Oct 2010 A1
20100318087 Scribner et al. Dec 2010 A1
20100331850 Rabiner Dec 2010 A1
20110004213 Rabiner et al. Jan 2011 A1
20110009871 Rabiner Jan 2011 A1
20110029093 Bojarski et al. Feb 2011 A1
20110046746 Rabiner et al. Feb 2011 A1
20110098713 Rabiner et al. Apr 2011 A1
20110110114 Papac et al. May 2011 A1
20110118740 Rabiner et al. May 2011 A1
20110160870 Baumgartner et al. Jun 2011 A1
20110166306 Stansbury et al. Jul 2011 A1
20110313356 Rabiner et al. Dec 2011 A1
20120165941 Rabiner et al. Jun 2012 A1
20120262939 O'Leary et al. Oct 2012 A1
20120289968 Rabiner Nov 2012 A1
20130003406 O'Leary et al. Jan 2013 A1
20130006304 Rabiner et al. Jan 2013 A1
20130013008 Rabiner et al. Jan 2013 A1
20130013009 Colleran et al. Jan 2013 A1
20130013010 Rabiner et al. Jan 2013 A1
20130023876 Rabiner et al. Jan 2013 A1
20130023886 Rabiner et al. Jan 2013 A1
20130041472 Rabiner et al. Feb 2013 A1
20130046390 Rabiner et al. Feb 2013 A1
20130066326 Rabiner et al. Mar 2013 A1
20130158607 Rabiner et al. Jun 2013 A1
20130184715 Rabiner et al. Jul 2013 A1
Foreign Referenced Citations (33)
Number Date Country
40 28 466 Mar 1992 DE
0 709 698 May 1996 EP
2001-527437 Dec 2001 JP
2004-526525 Sep 2002 JP
2005-511143 Apr 2005 JP
2006-212425 Aug 2006 JP
9001858 Mar 1992 NL
WO 9838918 Sep 1998 WO
WO 0243628 Jun 2002 WO
WO 03047472 Jun 2003 WO
WO 2004045393 Jun 2004 WO
WO 2004058045 Jul 2004 WO
WO 2004073563 Sep 2004 WO
WO 2004112661 Dec 2004 WO
WO 2005112804 Dec 2005 WO
WO 2006016807 Feb 2006 WO
WO 2007059259 May 2007 WO
WO 2007127255 Nov 2007 WO
WO 2007127260 Nov 2007 WO
WO 2008063265 May 2008 WO
WO 2009059090 May 2009 WO
WO 2009082688 Jul 2009 WO
WO 2009131999 Oct 2009 WO
WO 2010050965 May 2010 WO
WO 2010118158 Oct 2010 WO
WO 2011060062 May 2011 WO
WO 2011071567 Jun 2011 WO
WO 2011162910 Dec 2011 WO
WO 2012088432 Jun 2012 WO
WO 2013013069 Jan 2013 WO
WO 2013013071 Jan 2013 WO
WO 2013013072 Jan 2013 WO
WO2013059609 Apr 2013 WO
Non-Patent Literature Citations (59)
Entry
Jovanovic et al., “Fixion Nails for Humeral Fractures, Injury”, Int. J. Care Injured, vol. 35, Issue 11, pp. 1140-1142, Nov. 2004.
Maruyama et al., “Metacarpal Fracture Fixation with Absorbable Polyglycolide Rods and Stainless Steel K Wires: A Biomechanical Comparison”, Journal of Biomedical Materials Research (Applied Biomaterials), vol. 33, Issue 1, pp. 9-12, Apr. 1996.
Waris et al., “Bioabsorbable Miniplating Versus Metallic Fixation for Metacarpal Fractures”, Clinical Orthopaedics and Related Research, No. 410, pp. 310-319, May 2003.
Waris et al., “Self-Reinforced Bioabsorbable Versus Metallic Fixation Systems for Metacarpal and Phalangeal Fractures: A Biomechanical Study”, The Journal of Hand Surgery, vol. 27A, No. 5, pp. 902-909, Sep. 2002.
PCT International Search Report based on PCT/US07/20402 dated Apr. 1, 2008.
PCT International Search Report based on PCT/US07/10050 dated Apr. 17, 2008.
PCT International Search Report based on PCT/US07/10038 dated Aug. 27, 2008.
PCT International Search Report based on PCT/US08/81929 dated Jan. 12, 2009.
PCT International Search Report based on PCT/US08/81924 dated Feb. 9, 2009.
PCT International Search Report based on PCT/US08/87630 dated Feb. 24, 2009.
PCT International Search Report based on PCT/US10/30275 dated Aug. 11, 2010.
PCT International Search Report based on PCT/US10/56219 dated Jan. 20, 2011.
PCT International Search Report based on PCT/US10/46003 dated May 24, 2011.
PCT International Search Report based on PCT/US11/38389 dated Sep. 22, 2011.
PCT International Search Report based on PCT/US11/66871 dated May 1, 2012.
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 29, 2009.
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Mar. 11, 2010.
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 30, 2010.
USPTO Office Action in U.S. Appl. No. 11/789,907 mailed May 11, 2010.
USPTO Office Action in U.S. Appl. No. 11/903,123 mailed Jul. 1, 2010.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Dec. 9, 2010.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Apr. 28, 2011.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Sep. 23, 2011.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Mar. 16, 2012.
USPTO Office Action in U.S. Appl. No. 12/262,411 mailed Sep. 1, 2010.
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Dec. 23, 2011.
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed May 11, 2012.
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Oct. 24, 2011.
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Apr. 4, 2012.
USPTO Office Action in U.S. Appl. No. 12/875,460 mailed Mar. 8, 2012.
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Dec. 27, 2011.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed May 29, 2012.
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Jun. 8, 2012.
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Jun. 26, 2012.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Jul. 6, 2012.
Extended European Search Report based on EP 07 75 6022 dated Jul. 30, 2012.
Extended European Search Report based on EP 07 75 6016 dated Jul. 30, 2012.
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Aug. 1, 2012.
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Aug. 2, 2012.
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Aug. 15, 2012.
PCT International Search Report based on PCT/US12/47447 dated Oct. 2, 2012.
PCT International Search Report based on PCT/US12/47446 dated Oct. 15, 2012.
PCT International Search Report based on PCT/US12/47444 dated Oct. 18, 2012.
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Oct. 25, 2012.
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Nov. 9, 2012.
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Dec. 3, 2012.
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jan. 17, 2013.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Dec. 14, 2012.
International Search Report and Written Opinion for PCT/US2012/061047 mailed Jan. 7, 2013.
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Jan. 22, 2013.
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed Jan. 23, 2013.
USPTO Office Action in U.S. Appl. No. 13/772,947 mailed Jun. 19, 2013.
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jul. 9, 2013.
Supplemental European Search Report based on EP 08 87 7881 dated May 15, 2013.
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Feb. 4, 2013.
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Mar. 13, 2013.
USPTO Office Action in U.S. Appl. No. 13/561,249 mailed Apr. 23, 2013.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Apr. 26, 2013.
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed May 13, 2013.
Related Publications (1)
Number Date Country
20130023877 A1 Jan 2013 US
Provisional Applications (1)
Number Date Country
61167276 Apr 2009 US
Continuations (1)
Number Date Country
Parent 12755784 Apr 2010 US
Child 13616416 US